Clinical trial
SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial…
NCT00225082 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00225082 |
|---|---|
| Title | SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function |
| Official title | SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial |
| Lead sponsor | Northwestern University, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | Nucleoside analogue switch |
| Enrollment | 12 |
| Start date | Nov 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Sep 23, 2005 |
| Last update posted | Oct 5, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: